Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 16 studies | 35% ± 14% | |
peripheral blood | 15 studies | 28% ± 7% | |
intestine | 11 studies | 29% ± 12% | |
kidney | 6 studies | 29% ± 7% | |
liver | 6 studies | 27% ± 12% | |
brain | 5 studies | 28% ± 8% | |
placenta | 4 studies | 57% ± 25% | |
bone marrow | 4 studies | 26% ± 6% | |
uterus | 4 studies | 43% ± 18% | |
prostate | 4 studies | 28% ± 8% | |
lymph node | 4 studies | 30% ± 17% | |
breast | 4 studies | 34% ± 4% | |
pancreas | 3 studies | 60% ± 22% | |
eye | 3 studies | 24% ± 7% | |
adrenal gland | 3 studies | 25% ± 6% | |
skin | 3 studies | 21% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 5794.85 | 226 / 226 | 100% | 240.06 | 406 / 406 |
pancreas | 100% | 4688.10 | 328 / 328 | 100% | 205.79 | 178 / 178 |
skin | 100% | 4249.89 | 1808 / 1809 | 100% | 222.02 | 472 / 472 |
esophagus | 100% | 2184.39 | 1444 / 1445 | 100% | 136.60 | 183 / 183 |
prostate | 100% | 3688.36 | 245 / 245 | 100% | 324.39 | 501 / 502 |
uterus | 100% | 3087.78 | 170 / 170 | 100% | 186.39 | 458 / 459 |
thymus | 100% | 3448.23 | 653 / 653 | 100% | 169.97 | 603 / 605 |
stomach | 100% | 2995.63 | 359 / 359 | 100% | 207.70 | 285 / 286 |
intestine | 100% | 2784.21 | 966 / 966 | 100% | 241.77 | 525 / 527 |
ovary | 100% | 2873.77 | 180 / 180 | 100% | 141.41 | 428 / 430 |
kidney | 100% | 2712.70 | 89 / 89 | 99% | 149.91 | 896 / 901 |
lung | 100% | 4042.06 | 578 / 578 | 99% | 197.12 | 1147 / 1155 |
breast | 100% | 3165.30 | 459 / 459 | 99% | 186.76 | 1106 / 1118 |
bladder | 100% | 3197.05 | 21 / 21 | 99% | 219.64 | 497 / 504 |
adrenal gland | 100% | 3732.00 | 258 / 258 | 98% | 164.29 | 226 / 230 |
brain | 97% | 1324.68 | 2570 / 2642 | 100% | 119.64 | 704 / 705 |
adipose | 100% | 3137.58 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 122.83 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 203.28 | 29 / 29 |
spleen | 100% | 5029.66 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 156.81 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 185.97 | 1 / 1 |
blood vessel | 100% | 3216.58 | 1330 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 1773.88 | 839 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 95% | 2071.69 | 886 / 929 | 0% | 0 | 0 / 0 |
muscle | 55% | 440.05 | 438 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006915 | Biological process | apoptotic process |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0001525 | Biological process | angiogenesis |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0001938 | Biological process | positive regulation of endothelial cell proliferation |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0043410 | Biological process | positive regulation of MAPK cascade |
GO_0045766 | Biological process | positive regulation of angiogenesis |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005615 | Cellular component | extracellular space |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005793 | Cellular component | endoplasmic reticulum-Golgi intermediate compartment |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005515 | Molecular function | protein binding |
Gene name | MYDGF |
Protein name | Myeloid-derived growth factor (MYDGF) Myeloid derived growth factor |
Synonyms | C19orf10 |
Description | FUNCTION: Bone marrow-derived monocyte and paracrine-acting protein that promotes cardiac myocyte survival and adaptive angiogenesis for cardiac protection and/or repair after myocardial infarction (MI). Stimulates endothelial cell proliferation through a MAPK1/3-, STAT3- and CCND1-mediated signaling pathway. Inhibits cardiac myocyte apoptosis in a PI3K/AKT-dependent signaling pathway (By similarity). Involved in endothelial cell proliferation and angiogenesis . . |
Accessions | M0QXF7 ENST00000262947.8 M0QYN0 ENST00000599761.5 ENST00000599630.1 Q969H8 |